Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up

Transplantation

Volumn 81, Issue 5, 2006, Pages 692-696

  Bestetti, Reinaldo ^a,c   Theodoropoulos, Tatiana A D ^a   Burdmann, Emmanuel A ^b   Abbud Filho, Mário ^a,b   Cordeiro, José A ^b   Villafanha, Daniel ^a  

^a Sao Jose do Rio Preto Medical School   (Brazil)

^b Santa Casa de Misericórdia de São José Do Rio Preto Hospital   (Brazil)

^c NONE   (Brazil)

Author keywords

Cyclosporine; Heart transplantation; Mycophenolate mofetil; Nephrotoxicity; Sirolimus

Indexed keywords

AMINOTRANSFERASE; CALCINEURIN INHIBITOR; CREATININE; GLUCOSE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXALOACETIC ACID; POTASSIUM; RAPAMYCIN;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD CELL COUNT; CARDIAC GRAFT REJECTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RATE; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RECIPIENT; SURVIVAL RATE; THROMBOCYTE COUNT;

ADULT; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; CALCINEURIN; CHOLESTEROL; CREATININE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FAILURE; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; SIROLIMUS;

EID: 33645072757     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000177644.45192.a3     Document Type: Article

References (14)

1. John R, Rajasinghe HA, Chen JM, et al . Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy. Ann Thorac Surg 2001; 72: 440.
2. Burdmann EA, Yu L, Andoh TF, et al. Immunosuppressive drugs: calcineurin inhibitors and sirolimus. In: Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals. de Broe ME, Porter GA, Bennett WM, Verpooten GA, Eds. New York: Kluwer Academic Publishers, 2003.
3. Andoh TF, Burdmann EA, Fransechini N, et al . Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 1996; 50: 1110.
4. Snell GI, Levvey BJ, Chin W, et al . Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. J Heart Lung Transplant 2002; 21: 540.
5. Trosch F, Rothenburger M, Schneider M, et al . First experience with rapamycin-based immunosuppression to improve kidney function after heart transplantation. Thorac Cardiovasc Surg 2004; 52: 163.
6. Zakliczynski M, Nozynski J, Zakliczynska H, et al . Deterioration of renal function after replacement of cyclosporine with sirolimus in five patients with severe renal impairment late after heart transplantation. Transplant Proc 2003; 35: 2331.
7. Groetzner J, Meiser B, Landwehr P, et al . Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure. Transplantation 2004; 77: 568.
8. Bestetti RB. Role of parasites in the pathogenesis of Chagas' cardiomyopathy. Lancet 1996; 347: 913.
9. Mancini D, Pinney S, Burkhoff D, et al . Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003; 108: 48.
10. Zakliczynski M, Nozynski J, Swierad M, et al . Pathologic assessment of cardiomyocytes in heart transplant recipients treated with rapamycin or cyclosporine. Transplant Proc 2003; 35: 2329.
11. Venuta F, De Giacomo, T, Rendina EA, et al . Recovery of chronic renal impairment with sirolimus after lung transplantation. Ann Thorac Surg 2004; 78: 1940.
12. Renders L, Steinbach R, Valerius T, et al . Low-dose sirolimus in combination with mycophenolate mofetil improves kidney graft function late after renal transplantation and suggests pharmacokinetic interaction of both immunosuppressive drugs. Kidney Blood Press Res 2004; 27: 181.
13. Fairbanks KD, Eustace JA, Fine D, Thuluvath PJ. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus. Liver Transpl 2003; 9: 1079.
14. Lo A, Egidi MF, Gaber LW, et al . Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. Transplantation 2004; 77: 1228.